These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12713875)

  • 21. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
    Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
    Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
    Choi JW; Ahn SH; Park JY; Chang HY; Kim JK; Baatarkhuu O; Kim DY; Han KH; Chon CY
    J Med Virol; 2009 Apr; 81(4):594-601. PubMed ID: 19235871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relevancy between liver injury, serum HBV-DNA, and intrahepatic HBcAg in young male chronic HBV carriers].
    Kim TH; Kim YS; Yeom JJ; Cho EY; Kim HS; Kim HC; Park DS; Cho JH; Yoon GJ; Moon HB
    Korean J Gastroenterol; 2004 Aug; 44(2):84-92. PubMed ID: 15329519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subcellular distribution and translocation of hepatitis B virus core protein in HepG2.2.15 cells].
    Pan XB; Han JC; Wei L; Peng DD; Gao Y
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):29-32. PubMed ID: 18226340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen.
    Ramalho F; Brunetto MR; Rocca G; Piccari GG; Batista A; Chiaberge E; Lavarini C; Dal Monte RP; Carneiro de Moura M; Bonino F
    J Hepatol; 1988 Aug; 7(1):14-20. PubMed ID: 3183349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
    Kamijo N; Matsumoto A; Umemura T; Shibata S; Ichikawa Y; Kimura T; Komatsu M; Tanaka E
    World J Gastroenterol; 2015 Jan; 21(2):541-8. PubMed ID: 25593470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Core promoter mutations of HBV isolated from patients with chronic hepatitis B in Guangxi].
    Fang ZL; Zhuang H; Ge XM; Yang JY; Wang XY; Gong J; Li RC; Ling R; Harrison TJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):477-8. PubMed ID: 12939180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
    Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on tissue expression of HBV in children with chronic hepatitis type B using Immunomax technique.
    Kasprzak A; Biczysko W; Zabel M; Wysocki J; Surdyk-Zasada J
    Pol J Pathol; 1999; 50(4):249-58. PubMed ID: 10721265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expressive features of HBsAg and HBcAg in the livers of chronic hepatitis B and its clinical significance].
    Le XH; Chen XC; Lin Q; Li MZ; Wang M; Liu SY; Yu ZY; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):41-3. PubMed ID: 17429532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flowcytometric quantitation of hepatitis B viral antigens in hepatocytes from regular and fine-needle biopsies.
    van der Laan LJ; Taimr P; Kok A; Sprengers D; Zondervan PE; Tilanus HW; Janssen HL
    J Virol Methods; 2007 Jun; 142(1-2):189-97. PubMed ID: 17328969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced intracellular retention of a hepatitis B virus strain associated with fulminant hepatitis.
    Inoue J; Ueno Y; Nagasaki F; Wakui Y; Kondo Y; Fukushima K; Niitsuma H; Shimosegawa T
    Virology; 2009 Dec; 395(2):202-9. PubMed ID: 19850315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoplasmic (but not nuclear) hepatitis B virus (HBV) core antigen reflects HBV DNA synthesis at the level of the infected hepatocyte.
    Gowans EJ; Burrell CJ; Jilbert AR; Marmion BP
    Intervirology; 1985; 24(4):220-5. PubMed ID: 3908390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern.
    Jazayeri SM; Dornan ES; Boner W; Fattovich G; Hadziyannis S; Carman WF
    J Infect Dis; 2004 May; 189(9):1634-45. PubMed ID: 15116300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hepatitis B virus-DNA in the liver by in situ hybridization using a biotinylated probe. Relation to HBcAg expression and histology.
    Naoumov NV; Daniels HM; Davison F; Eddleston AL; Alexander GJ; Williams R
    J Hepatol; 1993 Sep; 19(2):204-10. PubMed ID: 8301053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
    Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
    J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays.
    Zampino R; Marrone A; Finnström N; Eriksson T; Törmänen V; Hedrum A; Attanasio V; Rosario P; Utili R; Ruggiero G
    Infez Med; 2005 Jun; 13(2):86-96. PubMed ID: 16220028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
    Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
    J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.